Related references
Note: Only part of the references are listed.Favipiravir exposure and pregnancy outcome of COVID-19 patients
Zeynep Tirmikcioglu
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2022)
Role of favipiravir in the treatment of COVID-19
Shashank Joshi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients
Nurullah Okumus et al.
BMC INFECTIOUS DISEASES (2021)
The protective role of curcumin against toxic effect of nonylphenol on bone development
P. Alisan Suna et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2021)
Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial
Hong Zhao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Favipiravir use in children with COVID-19 and acute kidney injury: is it safe?
Yasemin Ozsurekci et al.
PEDIATRIC NEPHROLOGY (2021)
Emerging treatment strategies for COVID-19 infection
Maria Gavriatopoulou et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2021)
A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19
Yohei Doi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity
Suzanne J. F. Kaptein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection
Chang Li et al.
VIRUS RESEARCH (2020)
Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019
Margaux Louchet et al.
AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2020)
Impact of prenatal exposure to bisphenol A on pregnant rats: Fetal bone development and immunohistochemistry implications
Emre Atay et al.
TOXICOLOGY AND INDUSTRIAL HEALTH (2019)
Influenza virus polymerase inhibitors in clinical development
Frederick G. Hayden et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2019)
Favipiravir as a potential countermeasure against neglected and emerging RNA viruses
Leen Delang et al.
ANTIVIRAL RESEARCH (2018)
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
Yousuke Furuta et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2017)
Bone Alkaline Phosphatase and Tartrate-Resistant Acid Phosphatase: Potential Co-regulators of Bone Mineralization
Cecilia Halling Linder et al.
CALCIFIED TISSUE INTERNATIONAL (2017)
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
Daouda Sissoko et al.
PLOS MEDICINE (2016)
Broad Spectrum Antiviral Activity of Favipiravir (T-705): Protection from Highly Lethal Inhalational Rift Valley Fever
Amy L. Caroline et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Assessment of a Nonsteroidal Aromatase Inhibitor, Letrozole, in Juvenile Rats
Louise Pouliot et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2013)
The clinical significance of SWI/SNF complex in pancreatic cancer
Masakatsu Numata et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Atlas of rat fetal skeleton double stained for bone and cartilage
E Menegola et al.
TERATOLOGY (2001)